326 related articles for article (PubMed ID: 12779083)
1. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
Liu H; Zang C; Fenner MH; Possinger K; Elstner E
Breast Cancer Res Treat; 2003 May; 79(1):63-74. PubMed ID: 12779083
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
3. Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.
Zang C; Wächter M; Liu H; Posch MG; Fenner MH; Stadelmann C; von Deimling A; Possinger K; Black KL; Koeffler HP; Elstner E
J Neurooncol; 2003 Nov; 65(2):107-18. PubMed ID: 14686729
[TBL] [Abstract][Full Text] [Related]
4. [Effects of peroxisome proliferator-activated receptor gamma and its ligands on cytotrophoblast invasion in first trimester of pregnancy and mechanism thereof].
Li SJ; Shang T; Li SY; Li QL
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):174-8. PubMed ID: 17425848
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma.
Józkowicz A; Huk I; Nigisch A; Cisowski J; Weigel G; Dulak J
Acta Biochim Pol; 2003; 50(3):677-89. PubMed ID: 14515149
[TBL] [Abstract][Full Text] [Related]
6. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma.
Meier CA; Chicheportiche R; Juge-Aubry CE; Dreyer MG; Dayer JM
Cytokine; 2002 Jun; 18(6):320-8. PubMed ID: 12160520
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Magenta G; Borenstein X; Rolando R; Jasnis MA
BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
Zang C; Liu H; Posch MG; Waechter M; Facklam M; Fenner MH; Ruthardt M; Possinger K; Phillip Koeffler H; Elstner E
Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
[TBL] [Abstract][Full Text] [Related]
11. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.
Elstner E; Müller C; Koshizuka K; Williamson EA; Park D; Asou H; Shintaku P; Said JW; Heber D; Koeffler HP
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8806-11. PubMed ID: 9671760
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator.
Farrow B; O'Connor KL; Hashimoto K; Iwamura T; Evers BM
Surgery; 2003 Aug; 134(2):206-12. PubMed ID: 12947319
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways.
Hunter JG; van Delft MF; Rachubinski RA; Capone JP
J Biol Chem; 2001 Oct; 276(41):38297-306. PubMed ID: 11477074
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo.
Xin X; Yang S; Kowalski J; Gerritsen ME
J Biol Chem; 1999 Mar; 274(13):9116-21. PubMed ID: 10085162
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells.
Hetzel M; Walcher D; Grüb M; Bach H; Hombach V; Marx N
Thorax; 2003 Sep; 58(9):778-83. PubMed ID: 12947137
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
[TBL] [Abstract][Full Text] [Related]
17. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
18. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.
Clay CE; Namen AM; Atsumi G; Trimboli AJ; Fonteh AN; High KP; Chilton FH
J Investig Med; 2001 Sep; 49(5):413-20. PubMed ID: 11523697
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.
Yasugi E; Horiuchi A; Uemura I; Okuma E; Nakatsu M; Saeki K; Kamisaka Y; Kagechika H; Yasuda K; Yuo A
Dev Growth Differ; 2006 Apr; 48(3):177-88. PubMed ID: 16573735
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
Liu J; Lu H; Huang R; Lin D; Wu X; Lin Q; Wu X; Zheng J; Pan X; Peng J; Song Y; Zhang M; Hou M; Chen F
Cancer Chemother Pharmacol; 2005 Oct; 56(4):400-8. PubMed ID: 15838654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
